Rapamycin side effects
Searched over 200M research papers
Summary
10 papers analyzed
These studies suggest that rapamycin can cause side effects such as myocardial infarctions, mucositis, rash, metabolic issues, and disrupted triglyceride metabolism, but lower doses and intermittent dosing may reduce these effects, and it is generally safe and tolerable in older adults.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Side Effects of Rapamycin: A Comprehensive Overview
Common Side Effects of Rapamycin
Rapamycin, an mTOR inhibitor, is widely used for its immunosuppressive and antiproliferative properties. However, its use is associated with a range of side effects. Commonly reported side effects include mucositis, rash, hyperglycemia, hyperlipidemia, and hypophosphatemia. These side effects are distinct from those seen with traditional chemotherapy and require routine monitoring due to their potential severity.
Gastrointestinal and Dermatological Side Effects
In clinical settings, rapamycin has been linked to gastrointestinal issues such as nausea and diarrhea, particularly within the first month of therapy. Dermatological side effects, including acne and facial rash, have also been observed, with some patients experiencing these symptoms more frequently over the first year of treatment .
Metabolic and Cardiovascular Side Effects
Rapamycin disrupts triglyceride metabolism, leading to hypertriglyceridemia and increased plasma free fatty acids. This disruption is due to alterations in the insulin signaling pathway, which also results in higher fasting plasma glucose levels. Additionally, in animal studies, higher doses of rapamycin have been associated with focal myocardial infarction, although lower doses did not show signs of myocardial toxicity.
Immunosuppressive Effects
As an immunosuppressant, rapamycin can lead to immunosuppression, which may increase the risk of infections. However, studies have shown that intermittent dosing schedules or the use of rapamycin analogs can mitigate these effects, reducing the impact on glucose tolerance and the immune system .
Hematological Effects
In a study involving older adults, rapamycin treatment was associated with significant decrements in several erythrocyte parameters, including hemoglobin and hematocrit levels. These changes, however, did not manifest clinically significant effects during the short duration of the study.
Reproductive and Lymphatic Effects
Rapamycin has been shown to protect ovarian reserves against chemotherapy-induced damage by inhibiting the activation of primordial follicles without obvious side effects. Conversely, it impedes lymphangiogenesis, which can lead to prolonged wound edema and other lymphatic complications.
Strategies to Mitigate Side Effects
Research suggests that alternative dosing regimens and the use of rapamycin analogs can reduce the severity of side effects. For instance, intermittent dosing schedules have been found to minimize effects on glucose tolerance and immune function. Additionally, local delivery methods, such as rapamycin-loaded subcapsular microspheres, have shown promise in reducing systemic side effects while maintaining therapeutic efficacy.
Conclusion
While rapamycin offers significant therapeutic benefits, its use is accompanied by a variety of side effects that can impact multiple organ systems. Understanding these side effects and exploring strategies to mitigate them is crucial for optimizing rapamycin therapy. Further research and tailored treatment regimens may help in reducing the adverse effects, thereby enhancing the overall safety and efficacy of rapamycin.
Sources and full results
Most relevant research papers on this topic
